Ertugliflozin 是选择性的、口服有效的钠离子依赖的葡萄糖协同转运蛋白2 (SGLT2) 抑制剂，对h-SGLT2 的IC50值为 0.877 nM。Ertugliflozin在2型糖尿病中有研究价值。

PF-04971729 (Ertugliflozin) is a potent and selective inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2).

1210344-57-2

C22H25ClO7

436.88

埃格列净;PF-04971729;MK-8835

DMSO:46 mg/mL (105.29 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years